Home / Contract Awards / FDA Selects Four Firms to Develop Automated Biological Product Reporting Methods

FDA Selects Four Firms to Develop Automated Biological Product Reporting Methods

The Food and Drug Administration has awarded four companies contracts worth up to $75M each to develop automated methods for reporting adverse drug events.

IBM (NYSE: IBM), Acumen, Dovel Technologies and IQVIA Government Solutions will use artificial intelligence, machine learning, natural language processing and other automation techniques to create data collection and analysis systems for the FDA’s Center for Biologics Evaluation and Research, the agency said Thursday in a FedBizOpps notice.

FDA requires each contractor to offer indirect access to medical information of U.S. patients, including administrative and claims data and electronic health records.

The indefinite delivery/indefinite quantity contracts have a five-year ordering period.

The agency also selected the four companies to develop surveillance tools as part of the Biologics Effectiveness and Safety Initiative.

Check Also

CAE, ITility, ValidaTek Win Spots on $95M Air Force Advisory, Assistance Services IDIQ

CAE USA's mission solutions subsidiary, ITility and ValidaTek have won positions on a potential seven-year, $95M contract to provide advisory and assistance services to the U.S. Air Force.

USAID Awards 10 Spots on $2.5B SWIFT 5 Unrestricted Transition Support IDIQ

The U.S. Agency for International Development has awarded 10 companies positions on the unrestricted portion of a potential five-year, $2.5B contract to support U.S. foreign policy objectives by helping USAID’s office of transition initiatives advance democracy and stabilization efforts in countries facing political crises.